$CBIS is very pleased with the self-medicating patient interactions; it helps fast track their targeted product releases and provides them with key patient input for their observational and clinical studies.
(0)
(0)
Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!